Large Molecule Bioanalytical Testing Service Market Report: Trends, Forecast and Competitive Analysis

Large Molecule Bioanalytical Testing Service Market Report: Trends, Forecast and Competitive Analysis

The future of the global large molecule bioanalytical testing service market looks promising with opportunities in the oncology, infectious diseases, cardiology, and neurology therapeutic areas. The global large molecule bioanalytical testing service market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are increasing research and development expenditure in pharmaceutical and biopharmaceutical companies and rising share of large molecules in biopharmaceutical.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global large molecule bioanalytical testing service market report, please download the report brochure.

The study includes trends and forecast for the global large molecule bioanalytical testing service market by test type, type, phase, therapeutic area, end user, and region as follows:

By Test Type [Value ($ Million) shipment analysis for 2014 – 2025]:

• ADME (Absorption, Distribution, Metabolism and Excretion)
• PK (Pyruvate Kinase)
• PD (Partial Discharge)
• Bioavailability
• Bioequivalence
• Other Test

By Type [Value ($ Million) shipment analysis for 2014 – 2025]:

• Pharmacokinetics
• Anti Drug Antibody (ADA)
• Others

By Phase [Value ($ Million) shipment analysis for 2014 – 2025]:

• Preclinical
• With Antibody
• Without Antibody
• Clinical

By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:

• Oncology
• Infectious Diseases
• Cardiology
• Neurology
• Others

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

• Small and Mid Size Enterprise (SMEs)
• Large Firms

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Asia Pacific
• China
• India
• Japan
• The Rest of the World
• Brazil

Some of the large molecule bioanalytical testing service companies profiled in this report include Covance, IQVIA, Syneos Health, SGS, Toxikon, Intertek Group, Pace Analytical Services, Charles River Laboratory, ICON, and PPD.

Lucintel forecasts that anti drug antibody (ADA) will remain the largest segment over the forecast period due to increasing prevalence of chronic diseases as ADA assays support the development of large molecule drugs by detecting anti drug antibodies.

Within this market, small and medium enterprise will remain the largest segment by end user over the forecast period due to increasing investment in the biopharmaceutical industry to enhance productivity and efficiency which has driven the bio-manufacturers to increase their focus on outsourcing activities.

North America will remain the largest region over the forecast period due to presence of highly reliable, complex, and high-end pharmaceutical companies and rapid technological advancements in the region.

Features of the Global Large Molecule Bioanalytical Testing Service Market

• Market Size Estimates: Global large molecule bioanalytical testing service market size estimation in terms of value ($M) shipment.
• Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
• Segmentation Analysis: Global large molecule bioanalytical testing service market size by various segments, such as test type, type, phase, therapeutic area, and end user in terms of value.
• Regional Analysis: Global large molecule bioanalytical testing service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different test type, type, phase, therapeutic area, end user, and region for the global large molecule bioanalytical testing service market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global large molecule bioanalytical testing service market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global large molecule bioanalytical testing service market by test type (ADME, PK, PD, bioavailability, bioequivalence, and other test), type (pharmacokinetics, ADA, and others), phase (preclinical, with antibody, without antibody, and clinical), therapeutic area (oncology, infectious diseases, cardiology, neurology, and others), end user (SMEs and large firms), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which region will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global large molecule bioanalytical testing service market?

Q.5 What are the business risks and threats to the global large molecule bioanalytical testing service market?

Q.6 What are the emerging trends in this large molecule bioanalytical testing service market and the reasons behind them?

Q.7 What are some changing demands of customers in this large molecule bioanalytical testing service market?

Q.8 What are the new developments in this large molecule bioanalytical testing service market? Which companies are leading these developments?

Q.9 Who are the major players in this large molecule bioanalytical testing service market? What strategic initiatives are being implemented by key players for business growth?

Q.10 What are some of the competitive products and processes in this large molecule bioanalytical testing service market, and how big of a threat do they pose for loss of market share via material or product substitution?

Q.11 What M&A activities did take place in the last five years in the global large molecule bioanalytical testing service market?

Report Scope

Key Features Description

Base Year for Estimation 2019

Trend Period

(Actual Estimates) 2014-2019

Forecast Period 2020-2025

Pages More than 150

Market Representation / Units Revenue in US $ Million

Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling

Market Segments Test Type (ADME, PK, PD, Bioavailability, Bioequivalence, and Other Test), Type (Pharmacokinetics, ADA, and Others), Phase (Preclinical, With Antibody, Without Antibody, And Clinical), Therapeutic Area (Oncology, Infectious Diseases, Cardiology, Neurology, and Others), and End User (SMEs and Large Firms)

Regional Scope North America (USA, Mexico, and Canada), Europe (Norway, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Please note: *The report will be completed in 2-4 weeks upon order confirmation*